Bullish option flow detected in Iovance Biotherapeutics with 2,437 calls trading, 1.4x expected, and implied vol increasing almost 3 points to 92.33%. Aug-23 7.5 calls and Jan-25 12.5 calls are the most active options, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 0.02. Earnings are expected on August 8th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IOVA:
- Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer
- Iovance Biotherapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, August 8, 2023
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Iovance Biotherapeutics Announces Closing of $172.5 Million Common Stock Public Offering
- Biotech Alert: Searches spiking for these stocks today